肝纤维化发病机制与诊断的最新进展 - Suppr | 超能文献

相似文献

1

Recent advances in the pathogenesis and diagnosis of liver fibrosis.肝纤维化发病机制与诊断的最新进展

J Gastroenterol. 2008;43(5):315-21. doi: 10.1007/s00535-008-2181-x. Epub 2008 Jul 1.

2

Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis.结合非侵入性标志物进行肝脏硬度测量以改善B型病毒性肝硬化的诊断

J Clin Gastroenterol. 2009 Mar;43(3):267-71. doi: 10.1097/MCG.0b013e31816f212e.

3

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.超声剪切波弹性成像技术与 FibroScan®对肝纤维化的无创评估：比较研究。

J Hepatol. 2014 Sep;61(3):550-7. doi: 10.1016/j.jhep.2014.04.044. Epub 2014 May 9.

4

Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl- induced liver fibrosis in mice.人脐带间充质干细胞和小鼠骨髓细胞抗肝纤维化作用及其机制的研究。

Biomed Pharmacother. 2017 May;89:1378-1386. doi: 10.1016/j.biopha.2017.03.007. Epub 2017 Mar 19.

5

Liver fibrosis and chronic viral hepatitis.肝纤维化与慢性病毒性肝炎

Arch Med Res. 2007 Aug;38(6):644-51. doi: 10.1016/j.arcmed.2006.10.001.

6

High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.天冬氨酸氨基转移酶与丙氨酸氨基转移酶比值升高是原发性硬化性胆管炎患者肝硬化及预后不良的一项指标。

Liver Int. 2007 Jun;27(5):694-9. doi: 10.1111/j.1478-3231.2007.01471.x.

7

Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro.Raf激酶抑制蛋白表达下调在体内和体外均加剧肝纤维化。

Cell Physiol Biochem. 2016;40(1-2):49-61. doi: 10.1159/000452524. Epub 2016 Nov 14.

8

Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.通过逐步应用瞬时弹性成像和常规生物标志物优化乙型肝炎肝硬化检测

J Gastroenterol Hepatol. 2017 Feb;32(2):459-465. doi: 10.1111/jgh.13475.

9

Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C.使用 FIB-4 指数无创性评估慢性丙型肝炎纤维化进展。

J Viral Hepat. 2013 Jan;20(1):72-6. doi: 10.1111/j.1365-2893.2012.01635.x. Epub 2012 Jul 4.

10

Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro.单宁酸对四氯化碳诱导的体内外肝纤维化的改善作用。

J Pharmacol Sci. 2016 Jan;130(1):15-23. doi: 10.1016/j.jphs.2015.12.002. Epub 2015 Dec 15.

引用本文的文献

1

Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting.LOXL2 在肝细胞癌进展中的多重作用及其作为治疗靶点的潜力。

Int J Mol Sci. 2023 Jul 21;24(14):11745. doi: 10.3390/ijms241411745.

2

A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence.利用基因组学、分子生物标志物和人工智能实现原发性肝癌治疗的范式转变。

Cancers (Basel). 2023 May 17;15(10):2791. doi: 10.3390/cancers15102791.

3

Raman microspectroscopy and machine learning for use in identifying radiation-induced lung toxicity.

本文引用的文献

1

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.肝星状细胞：肝脏中具有多种形态、多功能且神秘的细胞。

Physiol Rev. 2008 Jan;88(1):125-72. doi: 10.1152/physrev.00013.2007.

2

Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.活体肝移植术后丙型肝炎复发患者通过瞬时弹性成像评估移植肝纤维化情况。

Transplantation. 2008 Jan 15;85(1):69-74. doi: 10.1097/01.tp.0000297248.18483.16.

3

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.